Natural killer cell counts in primary HIV infection predicts disease progression and immune restoration after treatment.
第一作者:
Yue,Wang
第一单位:
NHC Key Laboratory of AIDS Immunology (China Medical University), Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China; National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China; Key Laboratory of AIDS Immunology of Liaoning Province, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China; Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, 110001, China.
作者:
主题词
成年人(Adult);抗HIV药(Anti-HIV Agents);抗逆转录病毒治疗, 高效(Antiretroviral Therapy, Highly Active);CD4阳性T淋巴细胞(CD4-Positive T-Lymphocytes);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);疾病恶化(Disease Progression);女(雌)性(Female);HIV感染(HIV Infections);HIV-1(HIV-1);人类(Humans);杀伤细胞, 天然(Killer Cells, Natural);淋巴细胞计数(Lymphocyte Count);男(雄)性(Male);中年人(Middle Aged);预后(Prognosis);前瞻性研究(Prospective Studies);RNA, 病毒(RNA, Viral);治疗结果(Treatment Outcome);病毒载量(Viral Load)
DOI
10.1016/j.virol.2020.08.007
PMID
32920454
发布时间
2021-02-24
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文